Agilent Technologies launches new genetic analysis tool

Agilent Technologies has launched a versatile new microarray system which is designed to make it easier to analyse genetic disorders.

The new SurePrint G3 Human CGH plus SNP microarray platform allows analysis of chromosomal copy number changes and copy-neutral aberrations to be performed simultaneously and is available in both standardised and customised variants.

It is designed to offer the same workflow speed as current CGH-only microarrays, allowing them to be easily incorporated into existing research, while also offering compatibility with Agilent's Genomic Workbench software for further data analysis.

The manufacturer stated that the new device will deliver "resolution, accuracy and sensitivity" to life scientists researching developmental disorders and cancers.

Anniek De Witte, product manager for CGH microarrays at Agilent, said: "We're excited to be adding SNP probes to our widely-used CGH arrays, resulting in a powerful, highly efficient tool."

Last week, the company allied with Strand Scientific Intelligence to augment its GeneSpring bioinformatics system with new functions and applications.